Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial.
暂无分享,去创建一个
J. Rossi | B. Coiffier | R. Bouabdallah | N. Brousse | É. Lepage | C. Haioun | P. Solal-Céligny | J. Gabarre | C. Doyen | P. Brice | C. Tendler | B. Pignon | G. Tertian | C. Haïoun